Breaking News

Pfenex Partner Expands Production Capacity

Serum Institute to produce cGMP grade vaccine product

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfenex, Inc.’s manufacturing partner, Serum Institute of India Ltd., began construction of a new large-scale cGMP production facility for CRM197, which is used in a number of conjugate vaccines for diseases such as meningitis and pneumococcal bacterial infections. Pfenex CRM197 is a recombinant form expressed in Pseudomonas fluorescens using the Pfenex Expression Technology platform.   This new facility is scheduled for completion in 2014 and will be dedicated CRM197 production with annual capac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters